Matinas Biopharma (MTNB) vs Purple Biotech (PPBT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Matinas Biopharma is the larger company by market cap ($2.8 million vs $2.3 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Head-to-head
| Metric | MTNB | PPBT |
|---|---|---|
| Share price | $2.83 | $1.44 |
| Market cap | $2.77M | $2.34M |
| 1-day change | +2.17% | -1.37% |
| EPS (TTM) | $-17.55 | $-47.64 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $28.95 | $14.10 |
| 52-week low | $2.27 | $1.16 |
| Distance from 52-week high | -90.22% | -89.79% |
| Average volume | 405.99K | 1.28M |
| Shares outstanding | 979.52K | 1.63M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
MTNB vs PPBT FAQ
Which is bigger, Matinas Biopharma or Purple Biotech?
Matinas Biopharma (MTNB) is larger, with a market capitalization of $2.77M compared with $2.34M for Purple Biotech (PPBT).
Are Matinas Biopharma and Purple Biotech in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.